Kokot F
Katedra i Klinika Nefrologii, Endokrynologii i Chorób Przemiany, Materii Sl. AM w Katowicach.
Przegl Lek. 1998;55 Suppl 1:13-6.
Although prophecy in medicine is extremely difficult, I do not expect, that xenotransplantation will become reality in the first decade of the 21th century. However I expect introduction of safer and more effective immunosuppressive agents or even induction of selective immunologic tolerance in kidney transplant patients. I expect a significant decline in the number of uraemic patients with diabetic or hypertensive nephropathies, thanks to better prevention and treatment of these pathological states. I predict intensification of studies of renal fibroblasts responsible for progression and loss of renal parenchyma in nephropathies of different etiology. Gene therapy will become a reality both in inborn and acquired nephropathies although safety of this kind of therapy remains to be established. Finally I expect essential improvement of therapy in clinical settings induced by abnormal homeostatic function of the kidneys mostly thanks to our better understanding of the molecular background of this function.
虽然医学中的预测极其困难,但我并不认为异种移植会在21世纪的第一个十年成为现实。不过,我期望能引入更安全、更有效的免疫抑制剂,甚至能诱导肾移植患者产生选择性免疫耐受。我预计,由于对糖尿病和高血压性肾病这些病理状态的更好预防和治疗,尿毒症患者中患有糖尿病或高血压肾病的人数将大幅下降。我预测,针对不同病因肾病中导致肾实质进展和丧失的肾成纤维细胞的研究将会加强。基因治疗在先天性和后天性肾病中都将成为现实,尽管这种治疗的安全性仍有待确定。最后,我期望主要由于我们对肾脏这种功能的分子背景有了更好的理解,因肾脏内稳态功能异常而导致的临床病症的治疗能有实质性改善。